EXHIBIT 99.1 Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434$33.7 million of total revenue and other income, up from $26.4 million in Q2 2025. • Product Revenue: Up 434$74.7 million. • ANKTIVA Unit Growth: 467% unit sales volume growth in year-to-date 2025 compared to fiscal year 2024. ® ...